Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Medicine|February 26, 2025
AAV-based vectors for human diseases modeling in laboratory animalsTimur I Aliev, Dmitry V YudkinInternational Journal of Molecular Sciences|November 9, 2024
Regulation of HTT mRNA Biogenesis: The Norm and PathologyAlexandra E Zubkova, Dmitry V YudkinAdvances in Experimental Medicine and Biology|May 9, 2020
Mystery of Expansion: DNA Metabolism and Unstable RepeatsIrina V Grishchenko, Yana V Purvinsh, Dmitry V YudkinInternational Journal of Molecular Sciences|October 30, 2020
Cell Cultures for Virology: Usability, Advantages, and ProspectsAlexander A Dolskiy, Irina V Grishchenko, Dmitry V YudkinFrontiers in Medicine|February 23, 2023
AAV- based vector improvements unrelated to capsid protein modificationEkaterina M Shitik, Igor K Shalik, Dmitry V YudkinInternational Journal of Molecular Sciences|January 23, 2024
CXCR4 Is a Potential Target for Anti-HIV Gene TherapyAppolinaria K Prokopovich, Irina S Litvinova, Alexandra E Zubkova, et al.Gene Therapy|March 24, 2020
Reactivation of FMR1 gene expression is a promising strategy for fragile X syndrome therapyEkaterina M Shitik, Anastasia A Velmiskina, Alexander A Dolskiy, et al.International Journal of Molecular Sciences|December 11, 2022
miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene TherapyDarya A Savenkova, Aelita-Luiza A Makarova, Igor K Shalik, et al.Biomed Research International|December 7, 2017
Inhibitors of Histone Deacetylases Are Weak Activators of the FMR1 Gene in Fragile X Syndrome Cell LinesAlexander A Dolskiy, Vladimir O Pustylnyak, Andrey A Yarushkin, et al.Molecular Cytogenetics|November 28, 2017
X-derived marker chromosome in patient with mosaic Turner syndrome and Dandy-Walker syndrome: a case reportAlena S Telepova, Svetlana A Romanenko, Natalya A Lemskaya, et al.Pageof 3